Replies to post #202768 on Amarin Corp Plc (AMRN)

[bogatie]

JL - would love to read your thoughts on post 202768, given your medical expertise. Basic question - has the ICER model erroneously taken "adherence" data and made it their model for "discontinuation?" (I am concerned because any economic analysis that has a drop-out rate at twice reality, is going to skew data against the cost-effectiveness of Vascepa.) If they have incorrectly modeled the discontinuation rate, I plan to contact ICER as I don't want a negative reprot out there. (I ave 23,000 shares from 2013 so I am very "invested" both time and money, in the truth of Vascepa being presented)

Thanks

[Biobillionair]

Re ICER: you have input into there process. Wednesday are preliminary data...make your point know after Wednesday...got it? BB